EcoDrugPlus

Janus Kinase 2

Ensembl ID : ENSCSEG00000017489
Gene Symbol: JAK2
3 Cross references
198 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSCSEG00000005737
Gene Symbol: KRAS
3 Cross references
208 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSCSEG00000018777
Gene Symbol: MALT1
3 Cross references
198 Possible Orthologues:

Map Kinase-Activated Protein Kinase 5

Ensembl ID : ENSCSEG00000018343
Gene Symbol: LOC103397646
3 Cross references
178 Possible Orthologues:

Map Kinase-Activated Protein Kinase 5-Like

Ensembl ID : ENSCSEG00000009028
Gene Symbol: LOC103396963
3 Cross references
178 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSCSEG00000004500
Gene Symbol: MAPKAPK2
3 Cross references
186 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSCSEG00000016700
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSCSEG00000003433
Gene Symbol: MDM2
1 Cross references
285 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSCSEG00000021367
Gene Symbol: MET
3 Cross references
204 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSCSEG00000000934
Gene Symbol: MLST8
3 Cross references
195 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSCSEG00000008120
Gene Symbol: NPC1L1
1 Cross references
189 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSCSEG00000010713
Gene Symbol: NPC1L1
4 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).